Proximal Hypoglossal Nerve Stimulation Beneficial for Obstructive Sleep Apnea

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

FRIDAY, April 24, 2026 -- For adults with moderate-to-severe obstructive sleep apnea (OSA), proximal hypoglossal nerve stimulation (pHGNS) yields a clinically significant response versus control at month 7, according to a study published online April 21 in the Annals of Internal Medicine.

Atul Malhotra, M.D., from the University of California San Diego in La Jolla, and colleagues examined the efficacy and safety of pHGNS in adults with moderate-to-severe OSA in a seven-month randomized controlled trial followed by a six-month open-label extension conducted at 23 U.S. health centers. A total of 104 patients aged 22 years or older underwent implantation with pHGNS at baseline and were randomly assigned to begin therapy at month 1 (treatment group; 67 participants) or month 7 (control; 37 participants).

The researchers found that at month 7, 58.2 and 13.5 percent of patients assigned to treatment and control, respectively, achieved the primary end point (greater than 50 percent improvement from baseline in the apnea-hypopnea index [AHI] and AHI below 20 events/hour at month 7), and oxygen desaturation index was reduced by at least 25 percent in 68.7 and 37.8 percent of patients, respectively. In the treatment group, but not the control group, the median Epworth Sleepiness Scale score improved from baseline to month 7. There were no reports of serious procedure-related adverse events.

"pHGNS therapy provided clinically relevant improvements in AHI, sleep quality, and patient-reported outcomes," the authors write. "These findings support continued clinical evaluation of pHGNS therapy to treat OSA."

Several authors disclosed ties to the biopharmaceutical industry, including to LivaNova, which funded the study.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-04-25 01:43

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords